Insiders Trades

★ Sign in to follow

SW

Steven W. Weldon

US·SEC (Form 4)

GT Biopharma, Inc.

Cumul. flow

Total declarations

19

Company

1

▲ Purchases (0 ops.)

—

▼ Sales (17 ops.)

€196k

Latest filing published 23 Dec 2020 for GT Biopharma, Inc., €12k.

Filing timeline

BuySale

Steven W. Weldon

Insider track record

Disclosed buys

0

Disclosed sells

17

Signal history

Steven W. Weldon: trading record in brief

This profile gathers the share dealings of Steven W. Weldon in GT Biopharma, Inc. The record holds 19 filings, for trades running from 1 September 2017 to 22 December 2020.

No open-market purchase appears, only 17 sales worth €196k. Besides market trades, the filings include 2 share grants. Since January 2020: no purchases and 17 sales on the market.

Most recently, on 23 December 2020, the filings show an open-market sale worth €14k in GT Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Steven W. Weldon

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

GT Biopharma, Inc. (US)

Declarations18 total

▼

Steven W. Weldon

Executives21 Dec 2020GT Biopharma, Inc.

15,000 USD3SEC

50,000 shares@ US$0.306.7% of flowCommon StockSEC:0001356710-20-000003:0

▼

Steven W. Weldon

Executives21 Dec 2020GT Biopharma, Inc.

16,500 USD3SEC

50,000 shares@ US$0.337.3% of flowCommon StockSEC:0001356710-20-000003:1

▼

Steven W. Weldon

Executives21 Dec 2020GT Biopharma, Inc.

12,145 USD3SEC

35,722 shares@ US$0.345.4% of flowCommon StockSEC:0001356710-20-000003:2

▼

Steven W. Weldon

Executives22 Dec 2020GT Biopharma, Inc.

19,191 USD3SEC

47,978 shares@ US$0.408.5% of flowCommon StockSEC:0001356710-20-000003:3

▼

Steven W. Weldon

Executives16 Dec 2020GT Biopharma, Inc.

15,000 USD3SEC

50,000 shares@ US$0.306.7% of flowCommon StockSEC:0001356710-20-000002:0

▼

Steven W. Weldon

Executives17 Dec 2020GT Biopharma, Inc.

15,000 USD3SEC

50,000 shares@ US$0.306.7% of flowCommon StockSEC:0001356710-20-000002:1

▼

Steven W. Weldon

Executives17 Dec 2020GT Biopharma, Inc.

15,500 USD3SEC

50,000 shares@ US$0.316.9% of flowCommon StockSEC:0001356710-20-000002:2

▼

Steven W. Weldon

Executives18 Dec 2020GT Biopharma, Inc.

15,000 USD3SEC

50,000 shares@ US$0.306.6% of flowCommon StockSEC:0001356710-20-000002:3

▼

Steven W. Weldon

Executives11 Dec 2020GT Biopharma, Inc.

12,500 USD3SEC

50,000 shares@ US$0.255.6% of flowCommon StockSEC:0001356710-20-000001:0

▼

Steven W. Weldon

Executives11 Dec 2020GT Biopharma, Inc.

13,000 USD3SEC

50,000 shares@ US$0.265.8% of flowCommon StockSEC:0001356710-20-000001:1

▼

Steven W. Weldon

Executives14 Dec 2020GT Biopharma, Inc.

14,500 USD3SEC

50,000 shares@ US$0.296.5% of flowCommon StockSEC:0001356710-20-000001:3

▼

Steven W. Weldon

Executives14 Dec 2020GT Biopharma, Inc.

13,427 USD3SEC

46,300 shares@ US$0.296.0% of flowCommon StockSEC:0001356710-20-000001:4

▼

Steven W. Weldon

Executives15 Dec 2020GT Biopharma, Inc.

15,000 USD3SEC

50,000 shares@ US$0.306.7% of flowCommon StockSEC:0001356710-20-000001:5

▼

Steven W. Weldon

Executives15 Dec 2020GT Biopharma, Inc.

16,000 USD3SEC

50,000 shares@ US$0.327.2% of flowCommon StockSEC:0001356710-20-000001:7

▼

Steven W. Weldon

Executives14 Dec 2020GT Biopharma, Inc.

14,000 USD3SEC

50,000 shares@ US$0.286.3% of flowCommon StockSEC:0001356710-20-000001:2

▼

Steven W. Weldon

CFOExecutives13 May 2020GT Biopharma, Inc.

2,270 USD19SEC

2,269,708 shares@ US$0.0011.1% of flowcommon stockSEC:0000939798-20-000006:0

◆

Steven W. Weldon

CFOExecutives14 Aug 2019GT Biopharma, Inc.

0SEC

4,500,000 shares0common stockSEC:0000939798-19-000030:0

◆

Steven W. Weldon

CFOExecutives1 Sept 2017GT Biopharma, Inc.

0SEC

2,566,835 shares0common stockSEC:0000939798-17-000099:0

18 of 18 declarations